SCHEMBL12001619

SCHEMBL12001619

Nc1nccc(-n2nc(C(=O)N3CCOCC3)c3ccc(C4(O)CCc5cccnc54)cc32)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K14 Q99558 3/20 0.42
▸ KDM4E B2RXH2 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ MAPT P10636 1/20 0.35
▸ GRM5 P41594 1/20 0.34
▸ KIT P10721 2/20 0.34
▸ FLT3 P36888 2/20 0.34
▸ PIK3CD O00329 4/20 0.33
▸ PIK3R2 O00459 4/20 0.33
▸ PIK3CA P42336 4/20 0.33
▸ PIK3CB P42338 4/20 0.33
▸ PIK3CG P48736 4/20 0.33
▸ PIK3R5 Q8WYR1 4/20 0.33
▸ PIK3R3 Q92569 4/20 0.33
▸ POLB P06746 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12001556 1.00 MAP3K14 (0.42) MAP3K14KDM4EALDH1A1NPC1RAB9A
SCHEMBL12001559 1.00 MAP3K14 (0.42) MAP3K14KDM4EALDH1A1NPC1RAB9A
SCHEMBL11970986 0.86 MAP3K14 (0.58) MAP3K14GRM5
SCHEMBL11971143 0.86 MAP3K14 (0.58) MAP3K14GRM5
SCHEMBL11970884 0.86 MAP3K14 (0.58) MAP3K14GRM5
SCHEMBL12001524 0.82 PIK3CD (0.35) MAP3K14KDM4EALDH1A1NPC1RAB9A
SCHEMBL11970664 0.80 MAPT (0.40) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL12001623 0.80 MAP3K14 (0.38) MAP3K14ROCK1
SCHEMBL11970555 0.78 DYRK3 (0.50) MAP3K14KDM4EALDH1A1NPC1RAB9A
SCHEMBL12001653 0.75 TTBK1 (0.38) KDM4EALDH1A1NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120214762-A1 6,5-HETEROCYCLIC PROPARGYLIC ALCOHOL COMPOUNDS AND USES THEREFOR GENENTECH, INC. (US) 2012-08-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120214762-A1 6,5-HETEROCYCLIC PROPARGYLIC ALCOHOL COMPOUNDS AND USES THEREFOR NFKB1, NFRKB, NFKBIA MAP3K14 519/4885KDM4E 3644/4885ALDH1A1 253/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback